CDNA – caredx, inc. (US:NASDAQ)

News

CareDx Announces VANTx™, an AI-Powered Clinical Data & Analytics Platform Built on CareDx's Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets [Yahoo! Finance]
CareDx Announces VANTx™, an AI-Powered Clinical Data & Analytics Platform Built on CareDx’s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets
CareDx (CDNA) was downgraded by Weiss Ratings from "hold (c-)" to "sell (d)".
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CareDx (CDNA) had its "buy" rating reaffirmed by BTIG Research.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com